Market Overview

Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

Related ZGNX
Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study
Morning Market Losers
Two Sub $2 Biotech Stocks On The Move (Seeking Alpha)

Shares of Zogenix (NASDAQ: ZGNX) rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th.

View pdf.

Posted-In: News FDA Movers


Related Articles (ZGNX)

Around the Web, We're Loving...